Næste

Automatisk afspilning

First-Line Treatment of HER2-Positive Metastatic Breast Cancer

2 Visninger • 07/03/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning